The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Study critique

Coming back to: A structured critique template this community uses

SO
s.okonkwoTL2 Moderator22 Apr 2026#1

Posting this under the heading it deserves: A structured critique template this community uses Everything below is what sits behind that.

Comparing STEP 8 (JAMA, 2022) with SURMOUNT-1 (N Engl J Med, 2022) and finding the comparison harder than it looks.

Different populations, different durations, different endpoints defined slightly differently, and in one case a different estimand. People compare the headline percentages anyway, including me until recently.

Is there a defensible way to put these side by side, or is the honest answer that there is not and we should stop?

45 likes 3mo
FA
f.abrahamsenTL2Member26 Apr 2026#2

On the opening post — agreed on the reasoning, with one qualification.

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

0 likes 3mo
KH
ka.haddadTL2 Moderator28 Apr 2026#3

Picking up post #2: that is the part I would want checked first.

Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not how you use the evidence. The point estimate and the precision both matter.

3 likes 3mo
AS
a.salcedoTL3Regular30 Apr 2026#4
f.abrahamsen, post #2: On the opening post — agreed on the reasoning, with one qualification. Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null. Go to post

Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question.

11 likes in reply to #2 3mo
MY
m.yilmazTL2 Moderator2 May 2026 · edited#5

Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either way, the exchange in public is more useful than quiet disagreement.

17 likes 3mo
SD
s.duarteTL2 Moderator4 May 2026#6

When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works.

0 likes 3mo
VB
v.bhattacharyaTL2 Moderator6 May 2026#7
f.abrahamsen, post #2: On the opening post — agreed on the reasoning, with one qualification. Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null. Go to post

This follows post #4 rather than contradicting it.

Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question. Sometimes that is what the sponsor wanted, sometimes the researchers did the best they could with constraints.

1 like in reply to #2 3mo
JD
j.dahlbergTL2 Moderator8 May 2026#8
ka.haddad, post #3: Picking up post #2: that is the part I would want checked first. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not how you use the evidence. The point estimate and the precision both matter. Go to post

I read post #6 twice before replying, because I had assumed the opposite.

Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing.

7 likes in reply to #3 3mo
TW
t.wojcikTL2 Moderator10 May 2026#9

post #8 answers the question as asked. The question underneath it is different.

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

0 likes 3mo
AK
a.kowalskiTL2 Moderator12 May 2026#10

What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample size" alone is weak. "Small sample size for a rare outcome, so the confidence interval is wide" is stronger.

1 like 3mo
I
IMainwaringTL3Regular13 May 2026#11

Coming back to post #9, because the follow-up matters more than the original answer.

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

19 likes 3mo
IB
i.beaulieuTL215 May 2026#12
N
NLoughranTL3Regular17 May 2026#13

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

2 likes 2mo
VM
v.malinowskiTL2 Moderator18 May 2026#14

Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing.

0 likes 2mo
F
FFaulknerTL3Regular20 May 2026#15

Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question. Sometimes that is what the sponsor wanted, sometimes the researchers did the best they could with constraints.

13 likes 2mo
SM
so.mbekiTL2 Moderator21 May 2026#16

This follows post #13 rather than contradicting it.

What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample size" alone is weak. "Small sample size for a rare outcome, so the confidence interval is wide" is stronger.

4 likes 2mo
OT
osmolal_tableTL1Member23 May 2026#17
m.yilmaz, post #5: Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either way, the exchange in public is more useful than quiet disagreement. Go to post

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

0 likes in reply to #5 2mo
BA
b.adeyemiTL2 Moderator24 May 2026#18

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

0 likes 2mo
O
OstrowskiTL2Member26 May 2026#19

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

8 likes 2mo
HN
h.nwosuTL2 Moderator27 May 2026#20

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

2 likes 2mo
SR
s.rasmussenTL2 Moderator29 May 2026#21

When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works.

0 likes 2mo
FW
f.wojcikTL2 Moderator30 May 2026#22
h.nwosu, post #20: Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence. Go to post

Coming back to post #20, because the follow-up matters more than the original answer.

Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not how you use the evidence. The point estimate and the precision both matter.

0 likes in reply to #20 2mo
EO
e.okaforTL2 Moderator31 May 2026#23

post #22 answers the question as asked. The question underneath it is different.

Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for.

8 likes 2mo
LT
l.trevinoTL2 Moderator2 Jun 2026#24

Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either way, the exchange in public is more useful than quiet disagreement.

19 likes 2mo
OC
o.cousineauTL3Regular3 Jun 2026#25
FFaulkner, post #15: Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question. Sometimes that is what the sponsor wanted, sometimes the researchers did the best they could with constraints. Go to post

Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question.

27 likes in reply to #15 2mo
NV
n.vogelTL2 Moderator5 Jun 2026 · edited#26
s.rasmussen, post #21: When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works. Go to post

Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question. Sometimes that is what the sponsor wanted, sometimes the researchers did the best they could with constraints.

0 likes in reply to #21 2mo
CN
c.niemelTL3Regular6 Jun 2026#27

post #26 is right about the mechanism and I think understates the practical bit.

Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for.

4 likes 2mo
NN
n.nakamuraTL2 Moderator7 Jun 2026#28

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

13 likes 2mo
ZO
z.okonkwoTL2 Moderator9 Jun 2026#29

What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample size" alone is weak. "Small sample size for a rare outcome, so the confidence interval is wide" is stronger.

0 likes 2mo
SS
system_suitabilityTL3Analytical chemist10 Jun 2026#30

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

4 likes 2mo